Basing treatment on rights rather than ability to pay: 3 by 5
Basing treatment on rights rather than ability to pay: 3 by 5
复制标题
基于权利而非支付能力的待遇:3 x 5
DOI:
10.1016/s0140-6736(04)15846-7
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
J. Mukherjee
中科院分区:
文献类型:
--
作者:
J. Mukherjee
If 3 by” 5 fails, as it surely will with-out the dollars, there will be no excuses left. Only the mass graves of the betrayed” said Stephen Lewis, UN Secretary-General’s special envoy for AIDS in Africa at a press briefing on March 3, 2004. The WHO/UNAIDS “3 by 5” initiative aims for 3 million people to be started on antiretroviral treatment by the end of 2005. 1 WHO estimates that US $5· 5 billion will be needed to meet the aims of 3 by 5. Yet, to date, less than $2.3 billion has been paid to the Global Fund. 2 Although AIDS is now treatable, less than 5% of the 40 million people living with AIDS have access to antiretrovirals. The 34 countries targeted by the initiative are home to 94% of people needing treatment in the developing world. An honest assessment of the global situation today shows that it is the market that decides who lives and who dies. The de-facto criterion for receiving antiretroviral treatment is the ability to pay for treatment. To address the greatest health crisis in the past 500 years, a human-rights based—rather than market-based—approach is the only realistic strategy for an epidemic that is concentrated in poor and marginalised communities who have neither access to health care nor the ability to pay for treatment. The 3 by 5 initiative proposes that governments consider universal access to AIDS treatment to be a basic human right in accordance with the Universal Declaration of Human Rights, which recognises the right to health care and the right to share in the advances of science. The 3 by 5 initiative also emphasises that these rights must be extended to vulnerable groups who risk being excluded from treatment because of social, economic, or geographical barriers. A striking aspect of the 3 by 5 initiative is that it recognises that highly HIV-burdened countries cannot succeed in tackling the epidemic without massive support from international agencies, donors, and other non-state entities. 1 Such support must include sustained financial assistance, not only for drugs, but also for medical staff and for capital investment in health infrastructure in heavily burdened countries. Donor countries must also allow generous interpretation of intellectual property rights with respect to AIDS-related treatment.The 1978 Alma-Ata declaration3 for “health care for all by the year 2000”, was perhaps the last time we heard such an ambitious and rightsbased call for access to health care. The rights-based goals of Alma-Ata were modest; 90% of children should have weight for age that corresponds to reference values, every family should be within a 15-minute walk of potable water, and women should have access to medically trained attendants for childbirth. Moreover, there was unanimous agreement that these goals could not be achieved without increased international aid. However, this proposed right to universal basic health care was attacked by international experts as naive and too expensive. In the next few decades distribution of limited resources for health was determined more by markets than by rights. With foreign debt mounting, poor countries were called upon by international financial institutions to decrease the proportion of gross national product spent on health as they moved towards market economies. Reforms